Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- DOCS +19.2% (also authorizes new $500 mln share repurchase program), DESP +10.4%, CAN +5.1%
Other news:
- RDDT +12.1% (partners with OpenAI (MSFT) to bring Reddit's content to ChatGPT and other OpenAI products)
- OUST +8.5% (CEO and two other insiders bought shares)
- APLD +4.9% (entered into a Dealer Manager Agreement for the offering of up to 2,000,000 shares of its Series E Redeemable Preferred Stock)
- NUVL +3.9% (FDA grants breakthrough therapy designation for NVL-655)
- OKLO +2.8% (Jacob DeWitte discloses 18.1% passive stake)
- ERAS +2.7% (license agreement with Guangzhou Joyo; prices offering of 86,486,486 shares of its common stock at $1.85 per share)
- ACDC +2.4% (CFO to step down, names new CFO)
- PH +2.2% (announces new five-year financial goals)
- KAI +2% (authorizes new $50 mln share repurchase program)
- MYGN +1.9% (announces new study publication)
- AMG +1.8% (acquires minority equity interest in Suma Capital)
- DV +1.5% (authorizes new $150 mln share repurchase program)
- VFF +1.5% (Applauds Historic Move Toward U.S. Marijuana Rescheduling)
- IART +1.1% (entered into an accelerated share repurchase agreement with Morgan Stanley to repurchase $50 million of outstanding shares of common stock; expected to be completed in the third quarter of 2024)
- PHG +0.9% (presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions)
- CB +0.8% (increases dividend)
- MRNS +0.8% (Announces Key Business Updates for Tuberous Sclerosis Complex Program)